Working… Menu
Help guide our efforts to modernize
Send us your comments by March 14, 2020.

Trial of Hypofractionated Intensity Modulated Radiation Therapy With Temozolomide and Granulocyte-macrophage Colony-stimulating Factor for Patients With Newly Diagnosed Glioblastoma Multiforme

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02663440
Recruitment Status : Unknown
Verified January 2016 by Zhejiang Cancer Hospital.
Recruitment status was:  Recruiting
First Posted : January 26, 2016
Last Update Posted : January 26, 2016
Information provided by (Responsible Party):
Zhejiang Cancer Hospital

No Study Results Posted on for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : December 2017
Study Completion Date : No date given